Molecular Pathology Protocols, edited by Dr. Anthony Killeen of the University of Michigan, is the 49th volume in the "Methods in Molecular Medicine" series from Humana Press. There are few as qualified as Dr. Killeen to edit such a work, given his long experience in the field of clinical molecular diagnostics. Dr. Killeen has assembled a top-notch set of authors and collected their works into an exceedingly useful book.
From the first chapters on the most basic aspects of molecular pathology and nucleic acid extraction to the last one on pharmacogenomics, each and every chapter of this book holds to an unwavering editorial principle promised in the preface, namely assemblage of a set of useful protocols that are described with brevity yet, amazingly, sufficient detail for virtually immediate implementation in the reader's laboratory.
Fundamental understanding of key molecular pathology controls and certain basics, such as potential interference by genomic DNA in reverse transcription-PCR (RT-PCR) amplification of cDNAs, are assumed by the authors, but importantly, they are not ignored altogether. Thus, the protocols in this book are most useful for experienced molecular laboratorians, but excellent "Notes" and "References" sections at the end of each chapter provide ample explanation and background material for beginning or intermediate-level molecular pathology laboratories to take advantage of the methods presented in Molecular Pathology Protocols.
Most of the chapters describe socalled "home-brew" methods used in the authors' laboratories. It is not surprising, therefore, that details down to specifying vendors are included, a major strength of the book. A very minor editorial criticism results then from the omission of a statement to the effect that many vendors exist for various aspects of the protocols, e.g., nucleic acid ex-traction, but this may well be assumed. Additionally, with respect to vendors, there is mention of one or two that no longer exist or are renamed (particularly problematic in chapter 10 on HER-2/neu gene amplification, which includes a description of reagents no longer available from the defunct vendor and does not mention the replacement vendor), but these are minor criticisms of a highly useful book.
In preparing to write this review, I sat down with my notes taken during the reading of a chapter here or two chapters there, and these words and phrases kept recurring: to-thepoint, concise, handy, brevity, practical, clear, excellent methodological description, complete, detailed, precise, clear step-by-step protocols, important protocol, comprehensive, all you need to get started, and so forth. As a compelling complement, the figures are useful, informative, and well placed. Use these protocols to implement research projects for your residents or to add to your existing laboratory test menu.
Chapters are included that describe less than mainstream, but nevertheless important, techniques for molecular diagnosticians and researchers. These simply serve to further demonstrate this book's wide appeal throughout all of molecular pathology. In other words, not every chapter describes a protocol you may want to implement in your laboratory, but there are enough, both diagnostic and research in nature, that make Molecular Pathology Protocols a book that every clinical molecular biology laboratory should have readily available. I highly recommend this book and urge you to consider visiting the publisher's website (http://www.humanapress. com) to review the focuses on the optimization of quality control using a commercially available computer program rather than on the broad topic of quality. The book contains 18 chapters and 4 appendices (my copy had an extra introduction because of a printing error). The premise underlying this book is that quality-control practices should be customized for the individual laboratory and individual analytes. The laboratorian starts with analytical performance and total error specifications for an individual analyte [usually from CLIA's proficiency testing limits or physiologically based intra-and interindividual variation (the so-called European Biologic Goals)]. Both sets of specifications are contained in the appendices. The total error specifications and analytical performance are transformed by Westgard's QC Validator Program to obtain "OP-Specs Charts", which are then interpreted to select the optimal qualitycontrol procedure. The theory and application of OPSpecs Charts have been well described by Westgard in print (Clinical Chemistry, MLO, and even Computer Methods and Programs in Biomedicine) and on his web site. 
